# PET/MRI in Patients With Suspected Prostate Cancer

> **NCT02659527** · PHASE3 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 220 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 68Ga- PSMA-HBED-CC
- **DEVICE:** Biograph mMR, Siemens

## Key facts

- **NCT ID:** NCT02659527
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2022-05
- **Final completion:** 2022-08
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02659527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02659527, "PET/MRI in Patients With Suspected Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02659527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*